Chronic neutropenia associated with autoimmune disease

Seminars in Hematology

Volumn 39, Issue 2, 2002, Pages 121-127

  Starkebaum, Gordon ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; CYTOKINE; FAS LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANEMIA; ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; FELTY SYNDROME; HUMAN; LEUKOCYTOCLASTIC VASCULITIS; NEUTROPENIA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; THROMBOCYTOPENIA;

EID: 0036220371     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/shem.2002.31918     Document Type: Article

References (58)

1. Post-splenectomy sepsis
2. Rheumatoid arthritis associated with expanded populations of granular lymphocytes
3. Proliferation of T gamma cells with killer-cell activity in two patients with neutropenia and recurrent infections
4. Large granular lymphocyte expansions in patients with Felty's syndrome: Analysis using anti-T cell receptor V beta-specific monoclonal antibodies
5. Hematologic and cytofluorographic analysis of patients with Felty's syndrome. A hypothesis that a discrete event leads to large granular lymphocyte expansions in this condition
6. The large granular lymphocyte syndrome with rheumatoid arthritis. Immunogenetic evidence for a broader definition of Felty's syndrome
7. Factors influencing the incidence of infections in Felty's syndrome
8. Immune complexes and the pathogenesis of neutropenia in Felty's syndrome
9. Splenic radiation for corticosteroid-resistant immune thrombocytopenia
10. The Felty syndrome: A case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations
11. Cyclosporine for the treatment of granulocytopenia in Felty's syndrome
12. Dialysis, neutropenia, lung dysfunction and complement
13. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: Relations with disease activity, antibodies to double stranded DNA, and neutropenia
14. + leukemic large granular lymphocytes utilize diverse T-cell receptor V beta genes
15. Depressed superoxide radical generation by neutrophils from patients with rheumatoid arthritis and neutropenia: Correlation with neutrophil reactive IgG
16. Parenteral gold therapy in the Felty syndrome. Experience with 20 patients
17. Cloning and expression of a novel human antibody-antigen pair associated with Felty's syndrome
18. Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infections
19. Chronic arthritis in the adult associated with splenomegaly and leukopenia
20. Reversal of neutropenia with methotrexate treatment in patients with Felty's syndrome. Correlation of response with neutrophil-reactive IgG
21. Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: A role for ribosomal P protein P0 as an endothelial cell autoantigen
22. Modulation of human neutrophil apoptosis by immune complexes
23. Severe neutropenia in a patient with large granular lymphocytosis: Prolonged successful control with cyclosporin A
24. Lack of evidence for the presence of neutrophil autoantibodies in the serum of patients with Felty's syndrome
25. Incidence of cancer among men with the Felty syndrome
26. Anti-granulocyte opsonic activity in sera from patients with systemic lupus erythematosus
27. Low-dose methotrexate for the treatment of patients with large granular lymphocyte leukemia associated with rheumatoid arthritis
28. Increased endothelial cell adherence, aggregation, and superoxide generation by neutrophils incubated in systemic lupus erythematosus and Felty's syndrome sera
29. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor
30. A new type of inclusion bodies in lymphocytes
31. Cutaneous vasculitis associated with granulocyte colony-stimulating factor
32. Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen
33. Splenectomy for Felty's syndrome. Clinicopathological study of 27 patients
34. Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE)
35. Chronic neutropenia mediated by fas ligand
36. Leukemia of large granular lymphocytes: Association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia
37. Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate
38. Large granular lymphocyte leukemia. Report of 38 cases and review of the literature
39. Storage histiocytes and hemophagocytosis: A common finding in the bone marrow of patients with active systemic lupus erythematosus
40. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus
41. Anti-elongation factor-1alpha autoantibody in adult atopic dermatitis patients
42. Constitutive expression of Fas ligand in large granular lymphocyte leukaemia
43. Clonal populations of T cells in normal elderly humans: The T cell equivalent to "benign monoclonal gammapathy"
44. Bone marrow findings in connective tissue disease
45. Improvement of extrathymic T cell type of large granular lymphocyte (LGL) leukemia by cyclosporin A: The serum level of Fas ligand is a marker of LGL leukemia activity
46. Neutropenia associated with T-cell large granular lymphocyte leukemia: Long-term response to cyclosporine therapy despite persistence of abnormal cells
47. Treatment of Felty's syndrome with the haemopoietic growth factor granulocyte colony-stimulating factor (G-CSF)
48. Use of colony-stimulating factors in the treatment of neutropenia associated with collagen vascular disease
49. Neutrophil-binding immunoglobulin G in systemic lupus erythematosus
50. Characterization of immune complexes and immunoglobulin G antibodies reactive with neutrophils in the sera of patients with Felty's syndrome
51. Immunogenetic similarities between patients with Felty's syndrome and those with clonal expansions of large granular lymphocytes in rheumatoid arthritis
52. Autoimmune neutropenia in systemic lupus erythematosus
53. Humoral and cellular immune mechanisms of neutropenia in patients with Felty's syndrome
54. Stimulation of human neutrophil chemiluminescence by soluble immune complexes and antibodies to neutrophils
55. Treatment of Felty's syndrome with leflunomide
56. Fas ligand in human serum
57. K-cell lymphocytosis/neutropenia syndrome: The neutropenia is not caused by autoimmunity
58. Methotrexate treatment in Felty's syndrome